18 completed, 12 recruiting, 9 unknown, 5 terminated. 18 Not applicable, 13 Phase 2, 11 Phase 1, 4 Phase 3, 1 Early Phase 1.
Follow Prostate Neoplasm: new trials by email Literature Review of Prostate Neoplasm trials Research Report on Prostate Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy fezolinetant - reference formulation, Placebo - Prostate Cancer, Prostate Cancer (Adenocarcinoma) | Phase 2 | Recruiting | Shehzad Basaria, M.D. | 60 | 2026-01-14 | 2026-08-17 |
| Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate Cancer Quantum Detection - Benign Prostate Hypertrophy(BPH), Prostate Cancer (Diagnosis) | Not yet recruiting | Shanghai Changzheng Hospital | 1100 | 2025-12-01 | 2025-11-20 | |
| A Study of LY4257496 in Participants With Cancer (OMNIRAY) LY4257496, Standard of Care Anticancer Therapies, LY4257529 - Breast Neoplasms, Colorectal Neoplasms | Phase 1 | Recruiting | Eli Lilly and Company | 421 | 2025-08-06 | 2026-10-07 |
| Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial surgery - Prostate Cancer (Adenocarcinoma), Prostate Cancer (Post Prostatectomy) | Not applicable | Recruiting | East and North Hertfordshire NHS Trust | 100 | 2025-04-22 | 2026-07-08 |
| Impact of Using the Airseal System With Ultra-low Pneumoperitoneum in Patients Undergoing Robot-assisted Radical Prostatectomy: A Prospective, Comparative, Randomized Clinical Study. The Conventional Insufflation System, AirSeal® System - Prostate Carcinoma, Prostate Neoplasm | Phase 4 | Recruiting | Brazilian Institute of Robotic Surgery | 200 | 2025-02-01 | 2025-01-20 |
| Prospective Study of Ultrahypofractionated Proton Beam Therapy for Localized Prostate Cancer Ultrahypofractionated Proton Beam Therapy - Prostate Neoplasm | Not applicable | Recruiting | National Cancer Center, Korea | 50 | 2024-11-04 | 2026-07-13 |
| Evaluating the Impact of Financial Navigation on Financial Catastrophe and Distress for Cancer Care Financial Navigation Program - Breast Neoplasm, Prostate Neoplasm | Not applicable | Recruiting | Northwestern University | 200 | 2024-07-15 | 2024-10-08 |
| Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study Radical prostatectomy, Prostate irradiation, Surgical metastasectomy - Prostate Cancer Metastatic, Prostate Cancer Metastatic to Bone | Not yet recruiting | Medical University of Vienna | 500 | 2024-05-31 | 2024-05-28 | |
| Effectiveness of Focal Therapy in Men With Prostate Cancer Focal therapy, Usual care - Prostate Cancer, Prostate Neoplasm | Not applicable | Recruiting | Radboud University Medical Center | 356 | 2024-02-01 | 2024-02-20 |
| Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer Patient 18F-PSMA-1007 - Prostate Cancer, Prostate Neoplasm | Suspended | Primo Biotechnology Co., Ltd | 230 | 2023-07-01 | 2026-07-06 | |
| MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy Risk Map Decision Support System (DSS)., Magnetic Resonance Imaging (MRI), Magnetic Resonance Imaging (MRI) Guided Biopsy - Prostate Cancer, Prostate Adenocarcinoma | Not applicable | Recruiting | University of Chicago | 180 | 2023-04-26 | 2026-09-01 |
| Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression observational study - Prostate Cancer, Prostate Adenocarcinoma | Recruiting | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 25 | 2023-03-20 | 2024-03-05 | |
| Protein Kinase A in Prostate Cancer Tissue. prostate biopsy - Prostate Neoplasm, Inflammation | Unknown | Ziv Hospital | 100 | 2023-03-01 | 2023-01-26 | |
| Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose. Abiraterone Oral Tablet, Prednisone tablet, Drug Dairy/Log - Prostate Cancer, Prostate Adenocarcinoma | Phase 1 | Terminated | University of Chicago | 50 | 2023-01-24 | 2025-10-03 |
| Addition of a Focal Boost in External Beam Radiotherapy for Locally Advanced Prostate Cancer by Online Adaptive MR-guided Radiotherapy Ultrahypofractionated MR-guided radiotherapy boost - Prostate Cancer, Prostate Neoplasm | Phase 2 | Not yet recruiting | Radboud University Medical Center | 95 | 2022-12-01 | 2022-11-07 |
| Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC NUV-422, Enzalutamide - Prostate Cancer, Prostatic Cancer | Phase 1 / Phase 2 | Withdrawn | Nuvation Bio Inc. | 2022-09-01 | 2022-08-05 | |
| NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors NUV-868, Olaparib, Enzalutamide - Advanced Solid Tumor, Ovarian Cancer | Phase 1 | Terminated | Nuvation Bio Inc. | 82 | 2022-03-29 | 2025-11-06 |
| Robotic-arm Assisted 68 Ga PSMA PET/CT Guided Prostate Biopsy Versus MR Directed Cognitive Fusion TRUS Guided Prostate Biopsy (PROBIOP) PSMA PET guided prostate biopsy, MRI directed TRUS guided prostate biopsy - Prostate Cancer, Prostate Neoplasm | Phase 2 / Phase 3 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 217 | 2021-10-25 | 2025-08-07 |
| Strength, Aging, and Memory in Prostate Cancer Prostate Neoplasm, Prostate Cancer | Completed | University of Nebraska | 20 | 2021-10-01 | 2024-09-19 | |
| Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy PET Scan, [18F]PSMA-1007 Injection, Sodium MRI - Prostate Cancer, Prostate Adenocarcinoma | Phase 2 | Completed | Glenn Bauman | 16 | 2021-02-04 | 2026-09-18 |
Showing 20 of 55. Sign in to see all of them.
Prostatic Neoplasms (55) · Breast Neoplasms (5) · Prostatic Neoplasms, Castration-Resistant (3) · Adenocarcinoma (2) · Esophageal Neoplasms (2) · Neoplasms (2) · Pain, Postoperative (2) · Pancreatic Neoplasms (2) · Prostatic Hyperplasia (2) · Rectal Neoplasms (2) · Urinary Bladder Neoplasms (2) · Brain Neoplasms (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Disease (1)
Genital Diseases (55) · Male Urogenital Diseases (55) · Neoplasms by Site (55) · Urogenital Diseases (55) · Genital Diseases, Male (54) · Genital Neoplasms, Male (54) · Prostatic Diseases (54) · Urogenital Neoplasms (54) · Neoplasms (53) · Pathological Conditions, Signs and Symptoms (8) · Female Urogenital Diseases (6) · Female Urogenital Diseases and Pregnancy Complications (6) · Breast Diseases (5) · Digestive System Diseases (5) · Pathologic Processes (5)
Multiparametric Magnetic Resonance Imaging (3) · enzalutamide (3) · Abiraterone Acetate (2) · Positron-Emission Tomography (2) · Radiotherapy (2) · ALT-803 (1) · Acetaminophen (1) · Diphenhydramine (1) · Docetaxel (1) · Electrocardiography (1) · High-Intensity Focused Ultrasound Ablation (1) · Ibuprofen (1) · Magnetic Resonance Imaging (1) · Magnetic Resonance Spectroscopy (1) · Naproxen (1)
National Cancer Institute (NCI) (3) · Nuvation Bio Inc. (3) · Radboud University Medical Center (3) · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (3) · Memorial Sloan Kettering Cancer Center (2) · Seoul National University Hospital (2) · Universitaire Ziekenhuizen KU Leuven (2) · University College, London (2) · University of Chicago (2) · Aarhus University Hospital (1) · Brazilian Institute of Robotic Surgery (1) · British Columbia Cancer Agency (1) · Cambridge University Hospitals NHS Foundation Trust (1) · Community Cancer Center, Normal, Illinois (1) · Crozer-Keystone Health System (1)
United States (23) · Canada (6) · United Kingdom (6) · China (5) · Netherlands (5) · South Korea (4) · Belgium (3) · Australia (2) · Denmark (2) · Germany (2) · Italy (2) · Brazil (1) · France (1) · India (1) · Japan (1)
Hongqian Guo, PhD (2) · Aytekin Oto, MD (1) · Bodil G. Pedersen, MD, PhD (1) · Caroline Moore, MD FRCS (1) · Cindy Mai, MD (1) · David Thurtle (1) · Diane Ehlers, PhD (1) · Frank Penedo, Ph.D. (1) · Heiko Schoder, MD (1) · Helena M Verkooijen, Prof, Dr (1) · Hiram A Gay, M.D. (1) · Hossein Jadvar, MD (1) · James L Gulley, M.D. (1)
PMID 20346578, PMID 21788033, PMID 22728263, PMID 23186377, PMID 23874588, PMID 29025845, PMID 29552975, PMID 29880049, PMID 30227893, PMID 31793032, PMID 32632561, PMID 33014774, PMID 33258023, PMID 33299276, PMID 33602696, PMID 33883176, PMID 34110033, PMID 34129229, PMID 34981300, PMID 35396316, PMID 35671523, PMID 36692682, PMID 37002379, PMID 37178932, PMID 38429598, PMID 40906325, PMID 41506574, PMID 41606671, PMID 41646304, PMID 41888042, PMID 42419881, PMID 42498485
2023 (1), 2025 (1), 5UT2CA244056 (1), P30CA014089 (1), R01CA206456 (1), R01CA283663 (1), R01EB031790 (1), R21CA277138 (1), R21EB017568 (1)